Search tips
Search criteria 


Logo of transoncolGuide for AuthorsAbout this journalExplore this journalTranslational Oncology
Transl Oncol. 2017 April; 10(2): 295–296.
Published online 2017 March 11. doi:  10.1016/j.tranon.2016.12.010
PMCID: PMC5348211

Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]

The authors mistakenly placed the figure of body weight change in mice treated with different agents in A549 cells (Supporting information Figure W4,B) with that of H460 cells (Supporting information Figure W4,A). The corrected Supporting information Figure W4 is attached below.

Figure W4
Body weight changes in tumor-bearing mice treated with BO-1509, LY294002, or the combination of BO-1509 and LY294002. A, H460 cells; B, A549 cells; C, PC9 cells, and D, PC9/gef B4.

Articles from Translational Oncology are provided here courtesy of Neoplasia Press